The effect of Cordyceps extract and a mixture of Ganoderma lucidum/Agaricus Blazi Murill extract on human endometrial cancer cell lines in vitro

Hahne,Jens C.; Meyer,Susanne R.; Dietl,Johannes; Honig,Arnd

doi:10.3892/ijo.2014.2414

The effect of Cordyceps extract and a mixture of Ganoderma lucidum/Agaricus Blazi Murill extract on human endometrial cancer cell lines in vitro

Authors:
- Jens C. Hahne
- Susanne R. Meyer
- Johannes Dietl
- Arnd Honig
View Affiliations

Affiliations: Department of Gynecology, Medical University of Würzburg, D-97080 Würzburg, Germany
Published online on: May 5, 2014 https://doi.org/10.3892/ijo.2014.2414
Pages: 373-382

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Endometrial carcinoma is the most common gynaecological malignancy. Nevertheless there is a lack of curative therapies, especially for patients diagnosed with late stage, recurrent or aggressive disease, who have a poor prognosis. Cordyceps Sinensis, Ganoderma lucidum and Agaricus Blazi Murill are three fungi widely used in traditional Chinese medicine, and effects as adjuvants in tumour therapy have been demonstrated. However, the function and effects of these fungi in regard to endometrial cancer are not known. Three endometrial cancer cell lines, Ishikawa, Hec-1A and AN3-CA (derived from endometrial cancers grade I, II and III, respectively), were used to determine the effect of the fungi extracts on endometrial cancer cell function and to analyze the molecular mechanism. All fungi extracts had an inhibitory effect on cell viability and proliferation most probably exerted through induction of autophagy. Our data suggest that these fungi extracts may be used as adjuvants in endometrial tumour therapy.

View Figures

View References

1.	Chaudhry P and Asselin E: Resistance to chemotherapy and hormone therapy in endometrial cancer. Endocr Relat Cancer. 16:363–380. 2009. View Article : Google Scholar : PubMed/NCBI
2.	Marnitz S and Köhler C: Current therapy of patients with endometrial carcinoma. A critical review. Strahlenther Onkol. 188:12–20. 2012. View Article : Google Scholar : PubMed/NCBI
3.	Patel S and Goyal A: Recent developments in mushrooms as anti-cancer therapeutics: a review. 3 Biotech. 2:1–15. 2012. View Article : Google Scholar : PubMed/NCBI
4.	Lindequist U, Niedermeyer TH and Jülich WD: The pharmacological potential of mushrooms. Evid Based Complement Alternat Med. 2:285–299. 2005. View Article : Google Scholar
5.	Lima CU, Cordova CO, Nóbrega Ode T, Funghetto SE and Karnikowski MG: Does the Agaricus blazei Murill mushroom have properties that affect the immune system? An integrative review. J Med Food. 14:2–8. 2011.
6.	Zhu JS, Halpern GM and Jones K: The scientific rediscovery of a precious ancient Chinese herbal regimen: Cordyceps sinensis: part II. J Altern Complement Med. 4:429–457. 1998. View Article : Google Scholar : PubMed/NCBI
7.	Li SP, Yang FQ and Tsim KW: Quality control of Cordyceps sinensis, a valued traditional Chinese medicine. J Pharm Biomed Anal. 41:1571–1584. 2006.
8.	Firenzuoli F, Gori L and Lombardo G: The medicinal mushroom Agaricus blazei Murrill: review of literature and pharmacotoxicological problems. Evid Based Complement Alternat Med. 5:3–15. 2008.
9.	Schmidt BM, Ribnicky DM, Lipsky PE and Raskin I: Revisiting the ancient concept of botanical therapeutics. Nat Chem Biol. 3:360–366. 2007. View Article : Google Scholar : PubMed/NCBI
10.	Zhao S, Ye G, Fu G, et al: Ganoderma lucidum exerts anti-tumor effects on ovarian cancer cells and enhances their sensitivity to cisplatin. Int J Oncol. 38:1319–1327. 2011.
11.	Chihara G, Maeda Y, Hamuro J, Sasaki T and Fukuoka F: Inhibition of mouse sarcoma 180 by polysaccharides from Lentinus edodes (Berk.). Nature. 222:687–688. 1969. View Article : Google Scholar : PubMed/NCBI
12.	Campling BG, Pym J, Galbraith PR and Cole SP: Use of the MTT assay for rapid determination of chemosensitivity of human leukemic blast cells. Leuk Res. 12:823–831. 1988. View Article : Google Scholar : PubMed/NCBI
13.	Hahne JC, Honig A, Meyer SR, et al: Downregulation of AKT reverses platinum resistance of human ovarian cancers in vitro. Oncol Rep. 28:2023–2028. 2012.PubMed/NCBI
14.	Traganos F and Darzynkiewicz Z: Lysosomal proton pump activity: supravital cell staining with acridine orange differentiates leukocyte subpopulations. Methods Cell Biol. 41:185–194. 1994. View Article : Google Scholar : PubMed/NCBI
15.	Jin X, Gossett DR, Wang S, et al: Inhibition of AKT survival pathway by a small molecule inhibitor in human endometrial cancer cells. Br J Cancer. 91:1808–1812. 2004. View Article : Google Scholar : PubMed/NCBI
16.	Block M, Fister S, Emons G, et al: Antiproliferative effects of antiestrogens and inhibitors of growth factor receptor signaling on endometrial cancer cells. Anticancer Res. 30:2025–2031. 2010.PubMed/NCBI
17.	Tsujimoto Y and Shimizu S: Another way to die: autophagic programmed cell death. Cell Death Differ. 12(Suppl 2): 1528–1534. 2005. View Article : Google Scholar : PubMed/NCBI
18.	González-Polo RA, Boya P, Pauleau AL, et al: The apoptosis/autophagy paradox: autophagic vacuolization before apoptotic death. J Cell Sci. 118:3091–3102. 2005.PubMed/NCBI
19.	Ouyang L, Shi Z, Zhao S, et al: Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif. 45:487–488. 2012. View Article : Google Scholar : PubMed/NCBI
20.	Amaral C, Borges M, Melo S, et al: Apoptosis and autophagy in breast cancer cells following exemestane treatment. PLoS One. 7:e423982012. View Article : Google Scholar : PubMed/NCBI
21.	Jiang J, Slivova V, Harvey K, Valachovicova T and Sliva D: Ganoderma lucidum suppresses growth of breast cancer cells through the inhibition of Akt/NF-κB signaling. Nutr Cancer. 49:209–216. 2004. View Article : Google Scholar
22.	Jin CY, Kim GJ and Choi YH: Induction of apoptosis by aqueous extract of Cordyceps militaris through activation of caspases and inactivation of Akt in human breast cancer MDA-MB-231 cells. J Microbiol Biotechnol. 18:1997–2003. 2008.
23.	Jiang J and Sliva D: Novel medicinal mushroom blend suppresses growth and invasiveness of human breast cancer cells. Int J Oncol. 37:1529–1536. 2010.PubMed/NCBI
24.	Calviño E, Manjón JL, Sancho P, et al: Ganoderma lucidum induced apoptosis in NB4 human leukemia cells: involvement of Akt and Erk. J Ethnopharmacol. 128:71–78. 2010.
25.	Dotan N, Wasser SP and Mahajna J: Inhibition of the androgen receptor activity by Coprinus comatus substances. Nutr Cancer. 63:1316–1327. 2011. View Article : Google Scholar : PubMed/NCBI
26.	Coutte L, Dreyer C, Sablin MP, Faivre S and Raymond E: PI3KAKT-mTOR pathway and cancer. Bull Cancer. 99:173–180. 2012.(In French).
27.	Hahne JC, Meyer SR, Gambaryan S, et al: Immune escape of AKT overexpressing ovarian cancer cells. Int J Oncol. 42:1630–1635. 2013.PubMed/NCBI
28.	Honig A, Hahne JC, Meyer S, et al: PI3K inhibitor D-116883 is effective in in vitro models of ovarian cancer. Anticancer Res. 32:2035–2041. 2012.PubMed/NCBI
29.	Pant A, Lee II, Lu Z, et al: Inhibition of AKT with the orally active allosteric AKT inhibitor, MK-2206, sensitizes endometrial cancer cells to progestin. PLoS One. 7:e415932012. View Article : Google Scholar : PubMed/NCBI
30.	Prasad R, Vaid M and Katiyar SK: Grape proanthocyanidin inhibit pancreatic cancer cell growth in vitro and in vivo through induction of apoptosis and by targeting the PI3K/Akt pathway. PLoS One. 7:e430642012. View Article : Google Scholar : PubMed/NCBI
31.	Wang RC, Wei Y, An Z, et al: Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation. Science. 338:956–959. 2012. View Article : Google Scholar : PubMed/NCBI
32.	Mizuno T: The extraction and development of antitumor-active polysaccharides from medicinal mushrooms in Japan (review). Int J Med Mushr. 1:9–30. 1999. View Article : Google Scholar
33.	Wasser SP and Weis AL: Medicinal properties of substances occurring in higher Basidiomycetes mushrooms: current perspectives (review). Int J Med Mushr. 1:31–62. 1999. View Article : Google Scholar
34.	Reshetnikov SV, Wasser SP and Tan KK: Higher basidiomycetes as a source of antitumor and immunostimulating polysaccharides (review). Int J Med Mushr. 3:361–394. 2001.
35.	Wasser SP: Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol. 60:258–274. 2002.PubMed/NCBI
36.	Xie YZ, Li SZ, Yee A, et al: Ganoderma lucidum inhibits tumour cell proliferation and induces tumour cell death. Enzyme Microb Technol. 40:177–185. 2006. View Article : Google Scholar
37.	Kiriakidis S, Högemeier O, Starcke S, et al: Novel tempeh (fermented soyabean) isoflavones inhibit in vivo angiogenesis in the chicken chorioallantoic membrane assay. Br J Nutr. 93:317–323. 2005. View Article : Google Scholar : PubMed/NCBI
38.	Wu WK, Coffelt SB, Cho CH, et al: The autophagic paradox in cancer therapy. Oncogene. 31:939–953. 2012. View Article : Google Scholar : PubMed/NCBI
39.	Carew JS, Kelly KR and Nawrocki ST: Autophagy as a target for cancer therapy: new developments. Cancer Manag Res. 4:357–365. 2012.